FDAnews Device Daily Bulletin

BOSTON SCIENTIFIC ANNOUNCES PRICING OF $750 MILLION OF SENIOR NOTES

Nov. 16, 2005
A A

Boston Scientific recently announced the pricing of a public offering of $750 million aggregate principal amount of its senior notes under the Company's existing shelf-registration statement. The public offering consists of $400 million of 5.50 percent notes due November 15, 2015 and $350 million of 6.25 percent notes due November 15, 2035.

PR Newswire (http://www.prnewswire.com/news/index_mail.shtml?ACCT=104&STORY=/www/story/11-14-2005/0004215845&EDATE=)